Marosi C - Search Results

1

Fakhrai N, Czech T, Diekmann K, Fazeny-Dörner B, Birner P, Hainfellner JA, Prayer D, Marosi C. Fakhrai N, et al. Among authors: marosi c. Strahlenther Onkol. 2004 Jul;180(7):455-7. doi: 10.1007/s00066-004-1293-3. Strahlenther Onkol. 2004. PMID: 15241534

2

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

Valencak J, Dietrich W, Raderer M, Dieckmann K, Prayer D, Hainfellner JA, Marosi C. Valencak J, et al. Among authors: marosi c. J Neurooncol. 2000 Sep;49(3):263-8. doi: 10.1023/a:1006405106553. J Neurooncol. 2000. PMID: 11212906 Review.

3

[Multimodal therapy of high-grade gliomas in adults].

Fazeny-Dörner B, Piribauer M, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Onkologie. 2001 Aug;24(4):376-9. doi: 10.1159/000055111. Onkologie. 2001. PMID: 11574766 Review. German.

4

Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine).

Fazeny-Dörner B, Veitl M, Wenzel C, Brodowicz T, Zielinski C, Muhm M, Vogelsang H, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Cancer Chemother Pharmacol. 2002 Apr;49(4):294-8. doi: 10.1007/s00280-001-0414-2. Epub 2002 Jan 30. Cancer Chemother Pharmacol. 2002. PMID: 11914908

5

Prognostic relevance of p53 protein expression in glioblastoma.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ungersböck K, Rössler K, Budka H, Hainfellner JA. Birner P, et al. Among authors: marosi c. Oncol Rep. 2002 Jul-Aug;9(4):703-7. Oncol Rep. 2002. PMID: 12066196

6

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

Bredel M, Piribauer M, Marosi C, Birner P, Gatterbauer B, Fischer I, Ströbel T, Rössler K, Budka H, Hainfellner JA. Bredel M, et al. Among authors: marosi c. Eur J Cancer. 2002 Jul;38(10):1343-7. doi: 10.1016/s0959-8049(02)00065-5. Eur J Cancer. 2002. PMID: 12091064

7

Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme.

Piribauer M, Fazeny-Dörner B, Rössler K, Ungersböck K, Czech T, Killer M, Dieckmann K, Birner P, Prayer D, Hainfellner J, Muhm M, Marosi C. Piribauer M, et al. Among authors: marosi c. Anticancer Drugs. 2003 Feb;14(2):137-43. doi: 10.1097/00001813-200302000-00007. Anticancer Drugs. 2003. PMID: 12569300 Clinical Trial.

8

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

Fazeny-Dörner B, Veitl M, Wenzel C, Rössler K, Ungersböck K, Dieckmann K, Piribauer M, Hainfellner J, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Br J Cancer. 2003 Feb 24;88(4):496-501. doi: 10.1038/sj.bjc.6600769. Br J Cancer. 2003. PMID: 12592361 Free PMC article. Clinical Trial.

9

Survival and prognostic factors of patients with unresectable glioblastoma multiforme.

Fazeny-Dörner B, Wenzel C, Veitl M, Piribauer M, Rössler K, Dieckmann K, Ungersböck K, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Anticancer Drugs. 2003 Apr;14(4):305-12. doi: 10.1097/00001813-200304000-00008. Anticancer Drugs. 2003. PMID: 12679735

10

Unexpected out-of-hospital deaths in persons aged 85 years or older: an autopsy study of 1886 patients.

Berzlanovich AM, Missliwetz J, Sim E, Fazeny-Dörner B, Fasching P, Marosi C, Waldhoer T, Muhm M. Berzlanovich AM, et al. Among authors: marosi c. Am J Med. 2003 Apr 1;114(5):365-9. doi: 10.1016/s0002-9343(03)00049-4. Am J Med. 2003. PMID: 12714125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page